THDB(SH:600867) Zheng Quan Shi Bao Wang·2025-11-12 09:43Core Viewpoint - Tonghua Dongbao has received the drug registration certificate for Aspart Insulin Injection from the Ministry of Public Health and Social Welfare of the Dominican Republic, indicating an expansion of its international market presence and the ability to meet the growing demand for diabetes treatment in the region [1][3]. Group 1: Product Approval and Market Demand - Aspart Insulin Injection is a rapid-acting insulin analog that starts to take effect within 10 to 20 minutes after subcutaneous injection and lasts for 3 to 5 hours, primarily used for controlling postprandial blood sugar [1]. - The Dominican Republic has seen a rising medical demand, with the International Diabetes Federation (IDF) reporting that in 2024, there will be approximately 1.2037 million diabetes patients aged 20-79, with a prevalence rate of 16.6% among adults in that age group [1]. - The average annual expenditure on diabetes-related healthcare per patient in the Dominican Republic is reported to be $1,353.9 [1]. Group 2: International Strategy and Product Expansion - Tonghua Dongbao is actively expanding its product portfolio, having received approvals for multiple insulin analogs and GLP-1 products in domestic and international markets [2]. - The company is focusing on emerging markets and countries involved in the Belt and Road Initiative for human insulin, while also pursuing partnerships to enter regulatory markets like the US and EU for insulin analogs [2]. - The company aims to enhance its international registration, overseas sales, and quality team, while deepening collaboration with global partners to promote more insulin and GLP-1 products abroad [2]. Group 3: Business Impact and Future Outlook - The approval of Aspart Insulin Injection in the Dominican Republic is expected to enrich the company's international product line, enhance brand image, and expand international business, thereby accelerating its presence in emerging markets [3]. - The company has initiated preliminary preparations for product manufacturing, although the specific sales performance may be influenced by market demand fluctuations, policy changes, and competitive dynamics [3].